\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ the\\ patient\\ first\\ underwent\\ egd\\ for\\ biopsy\\ and\\ then\\ underwent\\ surgical\\ resection\\ of\\ the\\ mass\\.\\ \\ the\\ patient\\ expired\\ approximately\\ nine\\ months\\ after\\ detection\\ of\\ the\\ cancer\\.\ \(0\)\
\-\ axial\\ ct\\ images\\ through\\ the\\ lower\\ thorax\\ and\\ upper\\ abdomen\\ following\\ the\\ administration\\ of\\ oral\\ and\\ iv\\ contrast\\ material\\ demonstrate\\ a\\ segment\\ of\\ significant\\ circumferential\\ wall\\ thickening\\ and\\ lumenal\\ narrowing\\ involving\\ the\\ distal\\ third\\ of\\ the\\ esophagus\\ and\\ the\\ proximal\\ aspect\\ of\\ the\\ stomach\\.\\ there\\ is\\ associated\\ lymphadenopathy\\.\ \(0\)\
\-\ pet\\/ct\\ fusion\\ images\\ in\\ axial\\,\\ sagital\\ and\\ coronal\\ planes\\ deomstrate\\ focal\\ increased\\ fdg\\-18\\ metabolism\\ in\\ the\\ region\\ of\\ wall\\ thickening\\ identified\\ on\\ the\\ ct\\ scan\\ with\\ a\\ maximum\\ suv\\ of\\ 11\\.6\\.\ \(0\)\
\-\ adenocarcinoma\\ of\\ the\\ gastroesophageal\\ junction\ \(0\)\
\-\ adenocarcinoma\\ in\\ a\\ barrett\\ esophagus\ \(0\)\
\-\ gastric\\ adenocarcinoma\\ with\\ extension\\ into\\ the\\ distal\\ esophagus\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 79\\ year\\ old\\ male\\ presents\\ with\\ dysphagia\\.\ \(1\)\
\-\ please\\ see\\ factoid\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ esophagus\\:\\ 0\\.07782320874264163\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.07744519813769034\ \(0\)\
\-\ 11\\.6\\.\\:\\ 0\\.06164698198577971\ \(0\)\
\-\ deomstrate\\:\\ 0\\.056799798904940926\ \(0\)\
\-\ fdg\\-18\\:\\ 0\\.056799798904940926\ \(0\)\
\-\ lumenal\\:\\ 0\\.05195261582410215\ \(0\)\
\-\ barrett\\:\\ 0\\.04554498832847869\ \(0\)\
\-\ pet\\/ct\\:\\ 0\\.042709567992057954\ \(0\)\
\-\ nine\\:\\ 0\\.04105649961398642\ \(0\)\
\-\ suv\\:\\ 0\\.04105649961398642\ \(0\)\
\-\ underwent\\:\\ 0\\.041009734761933134\ \(0\)\
\-\ egd\\:\\ 0\\.04069780524763991\ \(0\)\
\-\ thickening\\:\\ 0\\.04051223174396296\ \(0\)\
\-\ expired\\:\\ 0\\.040031300493763515\ \(0\)\
\-\ metabolism\\:\\ 0\\.03886309011150361\ \(0\)\
\-\ 79\\:\\ 0\\.038099458699161\ \(0\)\
\-\ sagital\\:\\ 0\\.03763308545091855\ \(0\)\
\-\ gastroesophageal\\:\\ 0\\.03639580777148443\ \(0\)\
\-\ circumferential\\:\\ 0\\.03620931653314764\ \(0\)\
\-\ maximum\\:\\ 0\\.03550943220757433\ \(0\)\
\-\ detection\\:\\ 0\\.03472287288291217\ \(0\)\
\-\ wall\\:\\ 0\\.034617610073269175\ \(0\)\
\-\ planes\\:\\ 0\\.03429017775201645\ \(0\)\
\-\ axial\\:\\ 0\\.03410897169325695\ \(0\)\
\-\ thorax\\:\\ 0\\.033882702870030604\ \(0\)\
\-\ distal\\:\\ 0\\.03249340683840597\ \(0\)\
\-\ dysphagia\\:\\ 0\\.029101804711950875\ \(0\)\
\-\ material\\:\\ 0\\.026701441609806875\ \(0\)\
\-\ gastric\\:\\ 0\\.026701441609806875\ \(0\)\
\-\ fusion\\:\\ 0\\.026654350475671603\ \(0\)\
\-\ please\\:\\ 0\\.026514950371470083\ \(0\)\
\-\ stomach\\:\\ 0\\.02642353721365643\ \(0\)\
\-\ segment\\:\\ 0\\.0260693852359029\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.025410733382338554\ \(0\)\
\-\ oral\\:\\ 0\\.02517889976473785\ \(0\)\
\-\ junction\\:\\ 0\\.02502850672123461\ \(0\)\
\-\ coronal\\:\\ 0\\.02488128008348753\ \(0\)\
\-\ administration\\:\\ 0\\.024808813041280908\ \(0\)\
\-\ narrowing\\:\\ 0\\.023961165693356625\ \(0\)\
\-\ third\\:\\ 0\\.023961165693356625\ \(0\)\
\-\ images\\:\\ 0\\.022926767719571386\ \(0\)\
\-\ iv\\:\\ 0\\.02180716739483282\ \(0\)\
\-\ n\\/a\\:\\ 0\\.021644801729783822\ \(0\)\
\-\ identified\\:\\ 0\\.021352916371932318\ \(0\)\
\-\ extension\\:\\ 0\\.02133096028798359\ \(0\)\
\-\ then\\:\\ 0\\.02126550264630832\ \(0\)\
\-\ biopsy\\:\\ 0\\.021200652039417907\ \(0\)\
\-\ involving\\:\\ 0\\.020967882965058\ \(0\)\
\-\ factoid\\:\\ 0\\.02094710135394501\ \(0\)\
\-\ first\\:\\ 0\\.020052331711789176\ \(0\)\
\-\ cancer\\:\\ 0\\.019644512338215143\ \(0\)\
\-\ aspect\\:\\ 0\\.018771272269114386\ \(0\)\
\-\ resection\\:\\ 0\\.018635773814826704\ \(0\)\
\-\ approximately\\:\\ 0\\.018488236549339742\ \(0\)\
\-\ proximal\\:\\ 0\\.017940861410538567\ \(0\)\
\-\ see\\:\\ 0\\.017833686791809706\ \(0\)\
\-\ abdomen\\:\\ 0\\.01770198785241746\ \(0\)\
\-\ focal\\:\\ 0\\.017066388840128684\ \(0\)\
\-\ through\\:\\ 0\\.016971727401544536\ \(0\)\
\-\ following\\:\\ 0\\.016959984313994043\ \(0\)\
\-\ region\\:\\ 0\\.016878330260414773\ \(0\)\
\-\ scan\\:\\ 0\\.01672917105197887\ \(0\)\
\-\ ct\\:\\ 0\\.016717533613874725\ \(0\)\
\-\ months\\:\\ 0\\.016321267795035437\ \(0\)\
\-\ significant\\:\\ 0\\.01606886119618338\ \(0\)\
\-\ metastatic\\:\\ 0\\.015042723102210422\ \(0\)\
\-\ increased\\:\\ 0\\.01461877469789969\ \(0\)\
\-\ upper\\:\\ 0\\.014420143394186841\ \(0\)\
\-\ into\\:\\ 0\\.01421906551020774\ \(0\)\
\-\ associated\\:\\ 0\\.014101136796557357\ \(0\)\
\-\ demonstrate\\:\\ 0\\.013751413575755529\ \(0\)\
\-\ the\\:\\ 0\\.013534895005949378\ \(0\)\
\-\ lower\\:\\ 0\\.013439594890656381\ \(0\)\
\-\ contrast\\:\\ 0\\.013376053753901437\ \(0\)\
\-\ surgical\\:\\ 0\\.012560991400359815\ \(0\)\
\-\ after\\:\\ 0\\.012363644773490926\ \(0\)\
\-\ presents\\:\\ 0\\.012207302765789692\ \(0\)\
\-\ patient\\:\\ 0\\.011980306726103328\ \(0\)\
\-\ male\\:\\ 0\\.010805633132080232\ \(0\)\
\-\ disease\\:\\ 0\\.009767395393116812\ \(0\)\
\-\ there\\:\\ 0\\.008893115779475446\ \(0\)\
\-\ in\\:\\ 0\\.00884050133161374\ \(0\)\
\-\ a\\:\\ 0\\.008320275562627998\ \(0\)\
\-\ mass\\:\\ 0\\.008310916132500451\ \(0\)\
\-\ and\\:\\ 0\\.007552825415337837\ \(0\)\
\-\ of\\:\\ 0\\.007332407043230042\ \(0\)\
\-\ year\\:\\ 0\\.006686050834076327\ \(0\)\
\-\ old\\:\\ 0\\.0061184237542815005\ \(0\)\
\-\ for\\:\\ 0\\.005098658382116889\ \(0\)\
\-\ on\\:\\ 0\\.0050621749116463504\ \(0\)\
\-\ is\\:\\ 0\\.0039321033453477315\ \(0\)\
\-\ with\\:\\ 0\\.002454633064822862\ \(0\)\
\-\ \\,\\:\\ 0\\.001893077381239772\ \(0\)\
\-\ \\.\\:\\ 0\\.00148949102506348\ \(0\)\
